Table 4.
Screening and treating barriersa
| Barriers Reported by Providers who Screen (N = 521) | n | % |
| None | 340 | 65.3% |
| Challenges with billing | 54 | 10.4% |
| Lack of onsite laboratory | 42 | 8.1% |
| Patient resistance/choice | 31 | 6.0% |
| Lack of phlebotomy services | 25 | 4.8% |
| Lack of staff to provide services | 23 | 4.4% |
| EMR education | 21 | 4.0% |
| Cost to patients | 11 | 2.1% |
| Lack of lab courier services | 7 | 1.3% |
| Reimbursement rates are too low/not cost effective | 8 | 1.5% |
| Provider time | 6 | 1.2% |
| Lack of supplies | 4 | 0.8% |
| Barriers Reported by Providers who Do Not Screen (N = 26) | ||
| No organizational support | 6 | 23.1% |
| Too busy/not enough time | 6 | 23.1% |
| Lack of phlebotomy services | 4 | 15.4% |
| Lack of onsite laboratory | 4 | 15.4% |
| Lack of staff to provide services | 3 | 11.5% |
| Only Treat | 3 | 11.5% |
| Challenges with billing | 2 | 7.7% |
| Lack of lab courier services | 1 | 3.8% |
| Barriers Reported by Providers who Treat (N = 153) | ||
| None | 73 | 47.7% |
| Lack of clinicians who treat Hepatitis C | 27 | 17.6% |
| Patient barriers | 23 | 15.0% |
| Challenges with billing | 20 | 13.1% |
| Lack of staff to provide services | 15 | 9.8% |
| Reimbursement rates are too low/ not cost effective | 9 | 5.9% |
| Unable to accept new patients/no available follow-up appointments | 6 | 3.9% |
| Need for education | 3 | 2.0% |
| Lack of lab resources | 1 | 0.7% |
| Barriers Reported by Providers who Do Not Treat (N = 410) | ||
| I do not feel I have adequate knowledge to treat Hepatitis C | 249 | 63.7% |
| Too busy/not enough time | 78 | 19.9% |
| No organizational support | 53 | 13.6% |
| I did not realize I could treat Hepatitis C | 49 | 12.5% |
| Inadequate staff support | 40 | 10.2% |
| I do not feel it should be part of my job | 35 | 9.0% |
| No clinic protocol to treat Hepatitis C | 7 | 1.8% |
| Reimbursement rates are too low/not cost effective | 3 | 0.8% |
aProviders could select multiple responses